Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 01 June 2012 | By Louise Zornoza
Health Canada is announcing a notice pertaining to the categorization of Therapeutic Products. The notice indicates a product's mode of action will not necessarily determine whether a product is a medical device or a drug, and previous decisions will not be a litmus test for future product classification.
In order to enhance transparency, Health Canada intends to develop guidance that will clarify what factor will determine whether a product will be classified as a drug or device.
Health Canada - Categorization of Therapeutic Products at the Device / Drug Interface
More Breaking News from RegLink
Tags: Classification, pharmaceutical, guidance, drug, medical device